133 related articles for article (PubMed ID: 21725608)
21. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018
[TBL] [Abstract][Full Text] [Related]
22. Skp2 is oncogenic and overexpressed in human cancers.
Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
[TBL] [Abstract][Full Text] [Related]
23. miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.
Yang CJ; Shen WG; Liu CJ; Chen YW; Lu HH; Tsai MM; Lin SC
J Oral Pathol Med; 2011 Aug; 40(7):560-6. PubMed ID: 21226887
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
26. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
27. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade.
Zhu DW; Yang X; Yang CZ; Ma J; Liu Y; Yan M; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Oral Oncol; 2013 Jun; 49(6):542-50. PubMed ID: 23403091
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of focal adhesion kinase in oral squamous cell carcinoma].
He ZX; He HW; Wang D; Fang MX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):876-8. PubMed ID: 17236584
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
30. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
31. ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma.
Grimm M; Krimmel M; Polligkeit J; Alexander D; Munz A; Kluba S; Keutel C; Hoffmann J; Reinert S; Hoefert S
Eur J Cancer; 2012 Nov; 48(17):3186-97. PubMed ID: 22784549
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
33. Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.
Chang KP; Yu JS; Chien KY; Lee CW; Liang Y; Liao CT; Yen TC; Lee LY; Huang LL; Liu SC; Chang YS; Chi LM
J Proteome Res; 2011 Nov; 10(11):4935-47. PubMed ID: 21859152
[TBL] [Abstract][Full Text] [Related]
34. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
35. IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.
Lai KC; Chang KW; Liu CJ; Kao SY; Lee TC
Mol Cancer Res; 2008 Sep; 6(9):1431-9. PubMed ID: 18819931
[TBL] [Abstract][Full Text] [Related]
36. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
[TBL] [Abstract][Full Text] [Related]
37. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
38. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
39. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451
[TBL] [Abstract][Full Text] [Related]
40. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
